ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the 13 Best Low Risk High Growth Stocks to Buy. The company witnesses ...

Adma has developed and commercialised three products that can be employed to ward off hundreds of illnesses to which the immuno-compromised are particularly susceptible, including Hepatitis B.

As far back as the 4th Century B.C., Aristotle marveled at the nimble gecko's ability to "run up and down a tree in any way, even with the head downwards." ...

CU Boulder scientists have taken a cue from the reptile to develop a material able to stick to tumors inside the body, ...

Adma Biologics (ADMA) concluded the recent trading session at $18.34, signifying a +2.98% move from its prior day's close.

Adma Biologics (ADMA) closed at $18.16 in the latest trading session, marking a -1.3% move from the prior day.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

Comparing ADMA Biologics's Short Interest Against Its Peers Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing.

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with advanced pulmonary arterial hypertension, according to a press release ...

As far back as the 4th Century B.C., Aristotle marveled at the nimble gecko's ability to "run up and down a tree in any way, even with the head downwards." ...